Lehtinen, Matti
Cross-protection is crucial for prophylactic HPV vaccination. [electronic resource]
- The Lancet. Infectious diseases Oct 2012
- 742-3 p. digital
Publication Type: Letter; Comment
1474-4457
10.1016/S1473-3099(12)70203-7 doi
Cross Protection
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Humans
Papillomavirus Infections--prevention & control
Papillomavirus Vaccines--immunology